Innovation Series 2022: Live with Ali Urman (Analyst, ARK Invest)
When: March 23rd, 2022
Where: Anywhere you are!
- Ali Urman (Analyst, ARK Invest)
- Lisa Langley (CEO/Founder, Emerge Canada)
What: Ali Urman (Analyst, ARK Invest) reviews the Big Ideas 2022 report and answers questions regarding the EAGB strategy.
Some of the questions asked:
- Where do you get your data from when it comes to clinical trial performance?
- Could you provide comments on new positions that have been added recently?
- What is something you’re optimistic about happening in the genomics space?